An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review). (Q36840684)
Jump to navigation
Jump to search
scientific article published on July 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review). |
scientific article published on July 2007 |
Statements
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review) (English)
Laura Ferrer-Soler
Alejandro Vazquez-Martin
Rafael De Llorens